Key Highlights

  • ADP (NASDAQ:ADP) is expected to report EPS of USD 2.77 before the open on October 28, 2026, one of 7 companies on a dense pre-market schedule, according to a published calendar.
  • Boston Scientific (NYSE:BSX) is seen at USD 0.75, a read on medical-device procedure volumes, while Biogen is seen at USD 2.02, a read on neuroscience drugs.
  • Garmin is seen at USD 2.39, Amphenol at USD 0.72, TE Connectivity at USD 3.07 and Otis at USD 1.01, giving mixed signals on consumer devices and industrial demand.
  • The results land before the Federal Reserve decision at 2:00 p.m. ET, so the slate sets the opening tone and supplies the first earnings data of a crowded day.

The Payroll and Healthcare Group

ADP (NASDAQ:ADP) is forecast at EPS of USD 2.77. As a payroll processor, it offers a read on employment trends, because its revenue grows with the number of workers it pays and with interest earned on client funds. Boston Scientific (NYSE:BSX) is forecast at USD 0.75, and the company is judged on procedure volumes, new device launches and hospital demand. Biogen (NASDAQ:BIIB) is forecast at USD 2.02, and its results depend on a small group of neuroscience drugs and a pipeline that investors will scrutinize. These are consensus estimates from one calendar, so they are approximate until each company reports. Because the group is large, a shared theme such as hiring, procedure demand or industrial orders may stand out across several reports.

The Industrial and Connectivity Group

Garmin (NYSE:GRMN) is forecast at USD 2.39, which will show whether consumer wearables and aviation products are still growing. Amphenol (NYSE:APH) is forecast at USD 0.72, a connector maker whose orders reflect industrial, automotive and data-center demand. TE Connectivity (NYSE:TEL) is forecast at USD 3.07 and sells similar parts. Otis (NYSE:OTIS) is forecast at USD 1.01, and its results show whether elevator installations and the service business are holding up. Together the group offers broad read-throughs on business investment, which matters after the large AI-related financing announcements this week. Each company has a different customer mix, so the signals will be mixed. A weaker consumer, tariff costs or a slowdown in factory orders would show up first in these results, so any shared caution would carry extra weight with investors.

Risks and What to Watch

With 7 reports in one morning, investors may struggle to separate company-specific results from macro moves. The Federal Reserve decision follows at 2:00 p.m. ET, with a hold priced near 93% and December hike odds near 73% to 75%, and a 10-year yield near 4.995% can weigh on valuations. For ADP (NASDAQ:ADP), hiring trends and interest on client funds are the swing factors. For the others, orders, margins and guidance matter most. None has reported yet, and the consensus figures come from a single calendar, so they are approximate and not confirmed by the companies. Because the group reports before the Federal Reserve statement, the reactions may be adjusted after 2:00 p.m. ET, and early moves in the shares should not be treated as final.

Where Things Stand

The answer is that ADP (NASDAQ:ADP) and the other 6 companies report before the open on October 28, 2026 because the calendar bunches them ahead of the Federal Reserve decision, and together they sketch employment, healthcare, consumer devices and industrial demand. The EPS estimates are approximate and no result is known yet. Guidance will matter more than any single quarter. This is not investment advice.